Tweenvest Stocks

Australis Capital Inc. (OTCPK: AUSA.F)

Health Care · Pharmaceuticals · US

$0.00

— today · -99.5% 1Y

Australis Capital Inc. (OTCPK: AUSA.F) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $254.00.

Over the last twelve months the share price has lost 99.5%, trading between 0.00 and 0.00.

Tweenvest scores Australis Capital Inc. across four factors: quality 34/100, value 50/100. Its strongest factor is value.

AUSA.F price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$254.00
Revenue (TTM)
$7.59M
P/E
—
EPS
-0.20
Dividend yield
—
Beta (5Y)
2,888.36
52-week high
$0.00
52-week low
$0.00
Avg volume (3M)
—
Shares outstanding
254.22M
Employees
—
Next earnings
—

About Australis Capital Inc.

Australis Capital Inc. operates as a cannabis company. It undertakes cannabis, as well as horticulture projects in the United States, Canada, Denmark Finland, Iceland, Germany, the Netherlands, Bahrein, the United Arab Emirates, Southeast Asia, and Australia, as well as other jurisdictions. The company is based in Las Vegas, Nevada.

ISIN
CA05259R1073
Founded
2018
Listed since
Sep 19, 2018
Exchange
Pink Sheets LLC
Currency
USD
CompanyMarket capPriceDay
Radiko Holdings Corp.OTCPK: GEAT.F$459.00$0.00—
The Flowr CorporationOTCPK: FLWP.F$426.00$0.00—
Nabriva Therapeutics plcOTCPK: NBRV.F$323.00$——
StateHouse Holdings Inc.OTCPK: STHZ.F$256.00$0.00—
Virpax Pharmaceuticals, Inc.OTCPK: VRPX$249.00$0.00-99.87%
Green Growth Brands Inc.OTCPK: GGBX.F$238.00$0.00—
Wayland Group Corp.OTCPK: MRRC.F$237.00$0.00—
Khiron Life Sciences Corp.OTCPK: KHRN.F$232.00$0.00—

Browse every Pharmaceuticals company →

Figures last refreshed Oct 11, 2026.